Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Erectile dysfunction (ED) affects many men in the UK, prompting interest in alternative treatments including cannabidiol (CBD). Whilst CBD has gained attention for various health applications, it is important to understand that there is currently no robust clinical evidence supporting its use for erectile dysfunction. This article examines what is known about CBD and erectile function, explores the lack of scientific support for CBD as an ED treatment, and outlines the evidence-based NHS-recommended approaches that have proven efficacy. Understanding the difference between unproven remedies and established treatments is essential for making informed decisions about managing erectile difficulties.
Summary: There is currently no robust clinical evidence supporting CBD as an effective treatment for erectile dysfunction, and neither NICE nor the MHRA recognises CBD for this indication.
Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It affects a significant proportion of men in the UK, with prevalence increasing with age. Whilst occasional difficulty with erections is normal, consistent problems warrant medical evaluation as ED can be an early indicator of underlying health conditions.
The causes of erectile dysfunction are multifactorial and can be broadly categorised into physical, psychological, and lifestyle-related factors. Physical causes include cardiovascular disease, diabetes mellitus, hypertension, hormonal imbalances (particularly low testosterone), neurological conditions, and medications such as certain antidepressants (SSRIs/SNRIs), antipsychotics, 5-alpha-reductase inhibitors, some beta-blockers, and opioids. Cardiovascular health is particularly important, as adequate blood flow to the penile tissues is essential for achieving an erection. Psychological factors such as anxiety, depression, stress, and relationship difficulties can significantly impact erectile function, often creating a cycle where anxiety about performance exacerbates the problem.
Lifestyle factors play a substantial role in erectile function. Smoking damages blood vessels and impairs circulation, whilst excessive alcohol consumption can affect both the nervous system and hormone levels. Obesity, physical inactivity, and poor diet contribute to conditions like diabetes and cardiovascular disease, which in turn affect erectile function. Understanding the underlying cause is crucial for effective management, as treatment approaches differ considerably depending on whether the primary issue is physical, psychological, or a combination of both. NICE guidelines emphasise the importance of comprehensive assessment, including morning testosterone measurements, HbA1c, lipid profile, blood pressure, and cardiovascular risk assessment to identify reversible causes before initiating specific ED treatments.
Cannabidiol (CBD) is a non-intoxicating compound derived from the cannabis plant that has gained attention for various potential therapeutic applications. Unlike tetrahydrocannabinol (THC), CBD does not produce psychoactive effects. It interacts with the body's endocannabinoid system, which plays a role in regulating numerous physiological processes including mood, pain perception, and inflammation.
Proponents suggest several theoretical mechanisms by which CBD might influence erectile function. Anxiety reduction is perhaps the most plausible pathway, as CBD has demonstrated anxiolytic properties in some studies, though evidence is limited to specific contexts and doses. Since performance anxiety and general anxiety disorders can contribute significantly to erectile difficulties, reducing anxiety might indirectly improve erectile function in some individuals. Additionally, some researchers have proposed potential anti-inflammatory effects that could theoretically influence vascular function, though it is important to emphasise that evidence specific to penile vasculature is lacking and largely speculative.
However, it is important to note that there is no official link established between CBD use and improved erectile function. The endocannabinoid system does have receptors in reproductive tissues, but the clinical significance of CBD's interaction with these receptors for erectile function remains unclear. Some research has even suggested that cannabis products containing THC may negatively impact sexual function and fertility. The relationship between cannabinoids and sexual health is complex and not fully understood, requiring further rigorous clinical investigation before any definitive conclusions can be drawn about CBD's efficacy for erectile dysfunction.
Currently, there is no robust clinical evidence supporting the use of CBD specifically for treating erectile dysfunction. Whilst CBD has been studied for various conditions including anxiety, chronic pain, and epilepsy (with one CBD medication, Epidyolex, licensed in the UK for certain seizure disorders), high-quality randomised controlled trials examining CBD's effects on erectile function are notably absent from the medical literature.
The existing evidence base consists primarily of preclinical studies, theoretical mechanisms, and anecdotal reports rather than rigorous human trials. Some animal studies have explored cannabinoids' effects on smooth muscle relaxation and vascular function, but these findings cannot be reliably extrapolated to human erectile function. The few human studies examining cannabis and sexual function have produced mixed results and typically involved THC-containing products rather than isolated CBD, making it difficult to draw conclusions about CBD specifically.
Regulatory perspective: The MHRA (Medicines and Healthcare products Regulatory Agency) has stated that CBD products making medical claims are medicines requiring a licence. Neither the MHRA nor NICE recognises CBD as an evidence-based treatment for erectile dysfunction. No NICE guideline or NHS resource recommends CBD for ED. CBD products available in the UK as food supplements are not licensed medicines and cannot legally make therapeutic claims about treating medical conditions. The European Medicines Agency (EMA) similarly does not endorse CBD for this indication.
Patients considering CBD for erectile dysfunction should be aware that they would essentially be experimenting without established efficacy data, appropriate dosing guidelines, or safety profiles specific to this use. The lack of evidence does not necessarily mean CBD is ineffective, but it does mean that claims about its benefits for ED are not currently supported by the scientific and medical consensus. Individuals experiencing erectile difficulties should prioritise evidence-based treatments recommended by healthcare professionals.
For individuals who choose to use CBD products despite the lack of evidence for erectile dysfunction, understanding quality and safety considerations is essential. The CBD market in the UK is regulated under the novel foods framework by the Food Standards Agency (FSA), though many products remain pending full authorisation.
Quality indicators to consider include:
Third-party testing: Reputable manufacturers provide certificates of analysis from independent laboratories confirming CBD content and absence of contaminants such as heavy metals, pesticides, and microbial contamination
Legal compliance: UK consumer CBD products should not contain detectable controlled cannabinoids (including THC, CBN, and THCV) under the Misuse of Drugs Act
Extraction methods: Various methods can produce quality CBD when properly implemented; focus on products with transparent manufacturing processes
Clear labelling: Products should clearly state CBD content per dose, ingredients, and batch numbers
Safety considerations are particularly important for individuals with erectile dysfunction, as they may have underlying cardiovascular conditions. The FSA advises healthy adults to limit CBD intake from food products to 10 mg per day and recommends that pregnant or breastfeeding women avoid CBD entirely. CBD can interact with certain medications, particularly those metabolised by cytochrome P450 enzymes (CYP3A4 and CYP2C19), including PDE5 inhibitors used for ED (sildenafil, tadalafil), some blood pressure medications, anticoagulants like warfarin, and certain statins. These interactions may increase the risk of side effects. Always consult a healthcare professional before combining CBD with prescribed medications.
Adverse effects of CBD are generally mild but can include fatigue, diarrhoea, changes in appetite, and alterations in liver enzyme levels at higher doses. If experiencing drowsiness, avoid driving or operating machinery. The long-term safety profile of regular CBD use remains incompletely characterised. Individuals should purchase from reputable UK suppliers on the FSA public list and remain cautious of exaggerated marketing claims. If you suspect side effects from CBD products, report them via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).
The NHS and NICE provide clear, evidence-based guidance for managing erectile dysfunction, with treatments tailored to underlying causes and individual circumstances. First-line approaches focus on lifestyle modifications and addressing reversible factors before progressing to pharmacological interventions.
Lifestyle modifications form the foundation of ED management and include:
Smoking cessation: Significantly improves vascular health and erectile function
Weight reduction: Particularly beneficial for overweight or obese individuals
Increased physical activity: Regular exercise improves cardiovascular health and erectile function
Alcohol moderation: Limiting intake to within recommended guidelines
Stress management: Addressing psychological factors through counselling or cognitive behavioural therapy
Pharmacological treatments are well-established and highly effective for most men. Phosphodiesterase type 5 (PDE5) inhibitors are the first-line medication option and include sildenafil, tadalafil, vardenafil, and avanafil. These medications work by enhancing the natural erectile response to sexual stimulation by increasing blood flow to the penis. They are effective in approximately 70% of men and are generally well-tolerated. Common side effects include headache, flushing, dyspepsia, nasal congestion, and visual changes. They are contraindicated in those taking nitrate medications (including recreational 'poppers') due to risk of dangerous blood pressure drops, and caution is needed with alpha-blockers. Cardiovascular risk assessment is recommended before initiating treatment.
For men who cannot use or do not respond to PDE5 inhibitors, second-line treatments include vacuum erection devices, intracavernosal injections (alprostadil), and intraurethral alprostadil. Testosterone replacement therapy may be appropriate for men with confirmed hypogonadism. In select cases, surgical options such as penile prosthesis implantation may be considered. Psychological therapy, either alone or combined with medical treatments, is recommended when psychological factors contribute significantly to ED. All these treatments have established efficacy and safety profiles, unlike CBD, making them the appropriate first choice for managing erectile dysfunction.
Erectile difficulties warrant medical consultation, particularly when they persist or cause distress. Men should contact their GP if they experience erectile problems on most occasions over a period of several weeks, as this may indicate an underlying health condition requiring attention.
Urgent medical assessment is necessary in certain circumstances:
Sudden onset ED: Particularly in younger men without obvious risk factors, as this may indicate a neurological or vascular problem
ED accompanied by chest pain, breathlessness, or cardiovascular symptoms: These may signal significant cardiovascular disease
Painful erections or penile deformity: Could indicate Peyronie's disease or other structural problems
Priapism: An erection lasting more than 4 hours requires emergency hospital assessment, especially following injection therapy
ED following trauma or surgery: May require specialist assessment
Associated symptoms: Such as reduced libido, fatigue, mood changes (suggesting hormonal issues), or urinary symptoms
It is particularly important to recognise that erectile dysfunction can be an early warning sign of cardiovascular disease. The blood vessels supplying the penis are smaller than coronary arteries, so vascular problems may manifest as ED before causing cardiac symptoms. NICE guidelines recommend cardiovascular risk assessment for all men presenting with ED.
Preparing for your appointment: Men should be ready to discuss their medical history, current medications (including over-the-counter products and supplements like CBD), lifestyle factors, and the nature of their erectile difficulties. GPs may perform physical examination, blood tests (including morning testosterone between 9-11 am, glucose, lipids), and blood pressure measurement. They can provide evidence-based treatment options, address underlying health conditions, and refer to specialist services when appropriate (urology for structural issues or PDE5 inhibitor failure; endocrinology for confirmed hypogonadism; cardiology if high cardiovascular risk). Self-treating with unproven remedies like CBD may delay diagnosis of important underlying conditions, so medical consultation should be the priority for anyone experiencing persistent erectile difficulties.
There is no robust clinical evidence that CBD helps with erectile dysfunction. Whilst CBD has anxiolytic properties that might theoretically address performance anxiety, high-quality human trials examining CBD's effects on erectile function are absent from medical literature, and neither NICE nor the MHRA recognises CBD as a treatment for ED.
CBD can interact with PDE5 inhibitors (sildenafil, tadalafil) and other medications metabolised by cytochrome P450 enzymes, potentially increasing side effect risk. Always consult your GP or pharmacist before combining CBD with prescribed erectile dysfunction treatments or other medications.
The NHS recommends lifestyle modifications (smoking cessation, weight reduction, increased physical activity) as first-line approaches, followed by PDE5 inhibitors such as sildenafil or tadalafil, which are effective in approximately 70% of men. Second-line options include vacuum devices, intracavernosal injections, and specialist referral when appropriate.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript